You are here

Home

Clinical Trials: Eye Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Tuesday, January 23, 2018 - 12:00
Effects of Xiidra on Closed Eye Tear Film Leukocytes in Dry Eye Disease
Conditions:   Ocular Discomfort;   Ocular Inflammation;   Dry Eye;   Contact Lens Complication;   Keratoconjunctivitis Sicca
Intervention:   Drug: Lifitegrast
Sponsors:   University of Alabama at Birmingham;   Shire
Not yet recruiting
Posted: Thursday, October 5, 2017 - 12:00
Corneal Epithelial Stem Cells and Dry Eye Disease
Conditions:   Dry Eye Syndromes;   Dry Eye;   Ocular Inflammation;   Ocular Surface Disease;   Ocular Discomfort;   Blepharitis
Intervention:   Other: Corneal Epithelial Stem Cell Transplant
Sponsor:   Sloan W. Rush, MD
Recruiting
Posted: Wednesday, September 27, 2017 - 12:00
Stem Cells for Corneal Haze
Conditions:   Corneal Haze After Photo Therapeutic/Refractive Keratectomy;   Corneal Haze After Collagen Cross Linking
Interventions:   Biological: stem cells after standard surgical therapy;   Other: Vehicle
Sponsor:   L.V. Prasad Eye Institute
Recruiting
Posted: Wednesday, May 24, 2017 - 12:00
Safety Assessment of Intravitreal Mesenchymal Stem Cells for Acute Non Arteritic Anterior Ischemic Optic Neuropathy
Condition:   Non Arteritic Ischemic Optic Neuropathy
Intervention:   Procedure: intravitreal injection of MSV
Sponsors:   Instituto Universitario de Oftalmobiología Aplicada;   University of Valladolid
Not yet recruiting - verified June 2017
Posted: Wednesday, May 24, 2017 - 12:00
A Phase 1b Dose Escalation Evaluation of Safety and Tolerability and a Phase 2 Proof of Concept Investigation of Efficacy and Safety of ASP7317 for Atrophy Secondary to Age-related Macular Degeneration
Condition:   Age-Related Macular Degeneration
Interventions:   Drug: ASP7317;   Other: Placebo;   Drug: Prograf®;   Drug: mycophenolate mofetil (MMF)
Sponsor:   Astellas Institute for Regenerative Medicine
Not yet recruiting - verified June 2017
Posted: Thursday, March 2, 2017 - 12:00
Safety and Efficacy of Intravitreal Injection of Human REtinal Progenitor Cells in Adults With Retinitis Pigmentosa
Condition:   Retinitis Pigmentosa
Intervention:   Biological: human retinal progenitor cells
Sponsor:   jCyte, Inc
Recruiting - verified March 2017
Posted: Thursday, February 2, 2017 - 12:00
Treatment of Dry Age Related Macular Degeneration Disease With Retinal Pigment Epithelium Derived From Clinical-grade Human Embryonic Stem Cells
Condition:   Dry Age-related Macular Degeneration
Intervention:   Biological: retinal pigment epithelium transplantation
Sponsors:   Chinese Academy of Sciences;   The First Affiliated Hospital of Zhengzhou University
Recruiting - verified December 2016
Posted: Sunday, January 1, 2017 - 12:00
Stem Cell Ophthalmology Treatment Study II
Conditions:   Retinal Disease;   Age-Related Macular Degeneration;   Retinitis Pigmentosa;   Stargardt Disease;   Optic Neuropathy;   Nonarteritic Ischemic Optic Neuropathy;   Optic Atrophy;   Optic Nerve Disease;   Glaucoma;   Leber Hereditary Optic Neuropathy
Interventions:   Procedure: Arm 1;   Procedure: Arm 2;   Procedure: Arm 3
Sponsor:   MD Stem Cells
Recruiting - verified January 2017
Posted: Thursday, October 20, 2016 - 12:00
Stem Cells Therapy for Corneal Blindness
Conditions:   Corneal Injuries;   Corneal Burns;   Corneal Scars and Opacities
Intervention:   Biological: Ex-vivo cultivated limbal stem cell pool
Sponsor:   L.V. Prasad Eye Institute
Recruiting - verified October 2016
Posted: Sunday, October 2, 2016 - 12:00
Autologous Adipose-Derived Adult Stem Cell Transplantation for Corneal Diseases
Conditions:   Hereditary Corneal Dystrophy;   Keratoconus
Interventions:   Procedure: Lipoaspiration;   Procedure: Transplantation
Sponsors:   Vissum, Instituto Oftalmológico de Alicante;   Reviva Pharmaceuticals;   Hospital Universitario La Paz;   LASER VISION CENTER IN LIBANON;   OPTICA GENERAL IN LIBANON
Recruiting - verified October 2016

Pages